Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers

NCT03822884 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Epoetin Alfa 40000 UNT/ML

Sponsor

Bio Sidus SA